is glp-1 safe Scientists cautiously suggest GLP-1s are to use around pregnancy Are GLP-1 Weight Loss Injections

Pain modulation Research reveals DSIP has analgesic properties

Journal of the American College of Nutrition , 39(5), 457-468

Long-acting amylin analog activating the amylin receptor complex (calcitonin receptor CALCR + receptor activity-modifying proteins RAMP1/2/3) via brainstem area postrema and hypothalamic circuits appetite suppression pathway distinct from GLP-1R

July 2024: Roche reported early clinical data for CT-996, its once-daily oral GLP-1 receptor agonist, showing clinically meaningful weight loss after four weeks and supporting further development in obesity and type 2 diabetes

1 Injection-site reactions and the formation of nodules or palpable bumps under the skin can also occur